David Shapiro Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Shapiro.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Shapiro. David Shapiro is Chief Medical Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and CMO & EVP - Development in INTERCEPT PHARMACEUTICALS INC ($ICPT) and CMO and EVP - Development in INTERCEPT PHARMACEUTICALS INC ($ICPT) and SEE REMARKS in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in ORGANOVO HOLDINGS, INC. ($ONVO).
Latest Insider Trading Transactions of David Shapiro
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 09 2019 | ONVO | ORGANOVO HOLDINGS, ... | Shapiro David | Director | Option Exercise | A | 0.27 | 52,000 | 13,832 | 52,000 | |
| May 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 9,031 | |
| May 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 86.28 | 2,000 | 172,560 | 39,499 | 41.5 K to 39.5 K (-4.82 %) |
| May 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 41,499 | 39.5 K to 41.5 K (+5.06 %) |
| Apr 16 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 11,031 | |
| Apr 16 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 95.00 | 2,000 | 190,000 | 39,499 | 41.5 K to 39.5 K (-4.82 %) |
| Apr 16 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 41,499 | 39.5 K to 41.5 K (+5.06 %) |
| Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 115.01 | 562 | 64,636 | 39,499 | 40.1 K to 39.5 K (-1.40 %) |
| Apr 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 111.50 | 482 | 53,743 | 40,061 | 40.5 K to 40.1 K (-1.19 %) |
| Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 13,031 | |
| Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 103.16 | 2,000 | 206,320 | 40,543 | 42.5 K to 40.5 K (-4.70 %) |
| Mar 01 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 42,543 | 40.5 K to 42.5 K (+4.93 %) |
| Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 15,031 | |
| Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 15,031 | |
| Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 111.51 | 2,000 | 223,020 | 40,543 | 42.5 K to 40.5 K (-4.70 %) |
| Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 111.51 | 2,000 | 223,020 | 40,543 | 42.5 K to 40.5 K (-4.70 %) |
| Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 42,543 | 40.5 K to 42.5 K (+4.93 %) |
| Feb 20 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 42,543 | 40.5 K to 42.5 K (+4.93 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | A | 110.80 | 5,300 | 587,240 | 5,300 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Grant | A | 0.00 | 3,300 | 0 | 40,543 | 37.2 K to 40.5 K (+8.86 %) |
| Jan 04 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 97.48 | 474 | 46,206 | 37,243 | 37.7 K to 37.2 K (-1.26 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 17,031 | |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 97.45 | 699 | 68,118 | 37,717 | 38.4 K to 37.7 K (-1.82 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 98.28 | 2,000 | 196,560 | 38,416 | 40.4 K to 38.4 K (-4.95 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 40,416 | 38.4 K to 40.4 K (+5.21 %) |
| Jan 03 2019 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 100.79 | 736 | 74,181 | 38,416 | 39.2 K to 38.4 K (-1.88 %) |
| Dec 19 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 31.90 | 2,000 | 63,800 | 19,031 | |
| Dec 19 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 106.62 | 2,000 | 213,240 | 39,152 | 41.2 K to 39.2 K (-4.86 %) |
| Dec 19 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 31.90 | 2,000 | 63,800 | 41,152 | 39.2 K to 41.2 K (+5.11 %) |
| Nov 02 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 21.50 | 2,000 | 43,000 | 361 | |
| Nov 02 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 96.32 | 2,000 | 192,640 | 39,152 | 41.2 K to 39.2 K (-4.86 %) |
| Nov 02 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 21.50 | 2,000 | 43,000 | 41,152 | 39.2 K to 41.2 K (+5.11 %) |
| Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | M | 21.50 | 3,425 | 73,638 | 2,361 | |
| Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 102.95 | 3,425 | 352,604 | 39,152 | 42.6 K to 39.2 K (-8.04 %) |
| Oct 16 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Buy | M | 21.50 | 3,425 | 73,638 | 42,577 | 39.2 K to 42.6 K (+8.75 %) |
| Oct 05 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 110.65 | 759 | 83,983 | 39,152 | 39.9 K to 39.2 K (-1.90 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 126.46 | 426 | 53,872 | 39,911 | 40.3 K to 39.9 K (-1.06 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 83.91 | 416 | 34,907 | 39,911 | 40.3 K to 39.9 K (-1.03 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 61.52 | 423 | 26,023 | 39,911 | 40.3 K to 39.9 K (-1.05 %) |
| Oct 03 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Payment of Exercise | F | 58.42 | 1,020 | 59,588 | 39,911 | 40.9 K to 39.9 K (-2.49 %) |
| Sep 07 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Sell | S | 111.43 | 4,917 | 547,891 | 42,196 | 47.1 K to 42.2 K (-10.44 %) |
| Feb 22 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Option Exercise | A | 58.74 | 4,400 | 258,456 | 4,400 | |
| Feb 22 2018 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | Chief Medical Offic ... | Grant | A | 0.00 | 2,900 | 0 | 47,113 | 44.2 K to 47.1 K (+6.56 %) |
| Oct 04 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 58.90 | 349 | 20,556 | 44,213 | 44.6 K to 44.2 K (-0.78 %) |
| Sep 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 31.90 | 1,250 | 39,875 | 21,031 | |
| Sep 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 117.43 | 1,250 | 146,788 | 44,562 | 45.8 K to 44.6 K (-2.73 %) |
| Sep 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 31.90 | 1,250 | 39,875 | 45,812 | 44.6 K to 45.8 K (+2.81 %) |
| Aug 02 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 1,118 | 9,689 | 0 | |
| Aug 02 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 119.00 | 1,118 | 133,042 | 44,562 | 45.7 K to 44.6 K (-2.45 %) |
| Aug 02 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 1,118 | 9,689 | 45,680 | 44.6 K to 45.7 K (+2.51 %) |
| Jul 13 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 124.01 | 553 | 68,578 | 44,562 | 45.1 K to 44.6 K (-1.23 %) |
| Jul 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 121.35 | 100 | 12,135 | 45,115 | 45.2 K to 45.1 K (-0.22 %) |
| Jul 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 121.20 | 250 | 30,300 | 45,215 | 45.5 K to 45.2 K (-0.55 %) |
| May 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 1,117 | 9,681 | 1,118 | |
| May 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 112.18 | 1,117 | 125,305 | 45,465 | 46.6 K to 45.5 K (-2.40 %) |
| May 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 1,117 | 9,681 | 46,582 | 45.5 K to 46.6 K (+2.46 %) |
| Apr 11 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 108.51 | 558 | 60,549 | 45,465 | 46 K to 45.5 K (-1.21 %) |
| Apr 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 115.00 | 346 | 39,789 | 46,023 | 46.4 K to 46 K (-0.75 %) |
| Mar 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 21.50 | 1,350 | 29,025 | 5,786 | |
| Mar 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 128.66 | 1,350 | 173,691 | 46,369 | 47.7 K to 46.4 K (-2.83 %) |
| Mar 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 21.50 | 1,350 | 29,025 | 47,719 | 46.4 K to 47.7 K (+2.91 %) |
| Feb 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | A | 107.18 | 10,000 | 1,071,800 | 10,000 | |
| Feb 03 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Grant | A | 0.00 | 6,000 | 0 | 46,369 | 40.4 K to 46.4 K (+14.86 %) |
| Jan 11 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 106.01 | 1,565 | 165,906 | 40,369 | 41.9 K to 40.4 K (-3.73 %) |
| Jan 05 2017 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 103.92 | 988 | 102,672 | 41,934 | 42.9 K to 41.9 K (-2.30 %) |
| Dec 06 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 99.75 | 1,350 | 134,663 | 42,922 | 44.3 K to 42.9 K (-3.05 %) |
| Oct 12 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 153.34 | 411 | 63,023 | 44,272 | 44.7 K to 44.3 K (-0.92 %) |
| Oct 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 21.50 | 1,350 | 29,025 | 8,486 | |
| Oct 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 163.20 | 163 | 26,602 | 44,683 | 44.8 K to 44.7 K (-0.36 %) |
| Oct 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 163.06 | 1,350 | 220,131 | 44,846 | 46.2 K to 44.8 K (-2.92 %) |
| Oct 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 21.50 | 1,350 | 29,025 | 46,196 | 44.8 K to 46.2 K (+3.01 %) |
| Sep 28 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 166.03 | 886 | 147,103 | 44,846 | 45.7 K to 44.8 K (-1.94 %) |
| Sep 28 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 164.76 | 2,659 | 438,097 | 45,732 | 48.4 K to 45.7 K (-5.49 %) |
| Jul 07 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 145.11 | 163 | 23,653 | 48,391 | 48.6 K to 48.4 K (-0.34 %) |
| Apr 06 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 130.76 | 165 | 21,575 | 48,546 | 48.7 K to 48.5 K (-0.34 %) |
| Feb 12 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | A | 95.74 | 10,200 | 976,548 | 10,200 | |
| Feb 12 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Grant | A | 0.00 | 7,800 | 0 | 48,711 | 40.9 K to 48.7 K (+19.07 %) |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 0 | |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 145.90 | 496 | 72,368 | 40,911 | 41.4 K to 40.9 K (-1.20 %) |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 145.90 | 37 | 5,398 | 41,407 | 41.4 K to 41.4 K (-0.09 %) |
| Jan 05 2016 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 41,444 | 39.8 K to 41.4 K (+4.08 %) |
| Dec 22 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 31.90 | 219 | 6,986 | 22,281 | |
| Dec 22 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 21.50 | 7,471 | 160,627 | 9,836 | |
| Dec 22 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,736 | 32,379 | 2,235 | |
| Dec 22 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 31.90 | 219 | 6,986 | 39,821 | 39.6 K to 39.8 K (+0.55 %) |
| Dec 22 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 21.50 | 7,471 | 160,627 | 39,602 | 32.1 K to 39.6 K (+23.25 %) |
| Dec 22 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,736 | 32,379 | 32,131 | 28.4 K to 32.1 K (+13.16 %) |
| Dec 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 0 | |
| Dec 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 157.45 | 1,000 | 157,450 | 28,395 | 29.4 K to 28.4 K (-3.40 %) |
| Dec 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 157.38 | 2,500 | 393,450 | 29,395 | 31.9 K to 29.4 K (-7.84 %) |
| Dec 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 31,895 | 28.4 K to 31.9 K (+12.33 %) |
| Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 3,500 | |
| Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 179.49 | 1,500 | 269,235 | 28,395 | 29.9 K to 28.4 K (-5.02 %) |
| Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 178.00 | 2,764 | 492,002 | 29,895 | 32.7 K to 29.9 K (-8.46 %) |
| Nov 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 32,659 | 29.2 K to 32.7 K (+12.00 %) |
| Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 7,000 | |
| Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 204.15 | 3,500 | 714,525 | 29,159 | 32.7 K to 29.2 K (-10.72 %) |
| Nov 12 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 32,659 | 29.2 K to 32.7 K (+12.00 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,622 | 0 | 1,623 | |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | A | 161.16 | 13,100 | 2,111,196 | 13,100 | |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 159.04 | 858 | 136,456 | 29,159 | 30 K to 29.2 K (-2.86 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 163.39 | 282 | 46,076 | 30,017 | 30.3 K to 30 K (-0.93 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,622 | 0 | 30,299 | 28.7 K to 30.3 K (+5.66 %) |
| Oct 05 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Grant | A | 0.00 | 5,150 | 0 | 28,677 | 23.5 K to 28.7 K (+21.89 %) |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 5,294 | 45,882 | 10,500 | |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 15,794 | |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 192.85 | 1,500 | 289,275 | 23,527 | 25 K to 23.5 K (-5.99 %) |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 191.04 | 1,000 | 191,044 | 25,027 | 26 K to 25 K (-3.84 %) |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 189.16 | 1,000 | 189,161 | 26,027 | 27 K to 26 K (-3.70 %) |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 5,294 | 45,882 | 27,027 | 21.7 K to 27 K (+24.36 %) |
| Sep 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 21,733 | 18.2 K to 21.7 K (+19.20 %) |
| Aug 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 19,294 | |
| Aug 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 209.37 | 4,272 | 894,429 | 18,233 | 22.5 K to 18.2 K (-18.98 %) |
| Aug 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,505 | 19 K to 22.5 K (+18.42 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,623 | 0 | 3,245 | |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 239.00 | 41 | 9,799 | 19,005 | 19 K to 19 K (-0.22 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 238.16 | 9 | 2,143 | 19,046 | 19.1 K to 19 K (-0.05 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 236.13 | 801 | 189,140 | 19,055 | 19.9 K to 19.1 K (-4.03 %) |
| Jul 07 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,623 | 0 | 19,856 | 18.2 K to 19.9 K (+8.90 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 22,794 | |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 241.81 | 100 | 24,181 | 18,233 | 18.3 K to 18.2 K (-0.55 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 240.59 | 381 | 91,664 | 18,333 | 18.7 K to 18.3 K (-2.04 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 239.32 | 398 | 95,251 | 18,714 | 19.1 K to 18.7 K (-2.08 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 238.51 | 1,902 | 453,641 | 19,112 | 21 K to 19.1 K (-9.05 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 237.64 | 1,000 | 237,640 | 21,014 | 22 K to 21 K (-4.54 %) |
| Jul 06 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,014 | 18.5 K to 22 K (+18.90 %) |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 26,294 | |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 242.05 | 1,900 | 459,896 | 18,514 | 20.4 K to 18.5 K (-9.31 %) |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 241.03 | 1,600 | 385,650 | 20,414 | 22 K to 20.4 K (-7.27 %) |
| Jun 17 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,014 | 18.5 K to 22 K (+18.90 %) |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 3,500 | 30,333 | 29,794 | |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 307.60 | 1,984 | 610,274 | 18,514 | 20.5 K to 18.5 K (-9.68 %) |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 306.31 | 2,295 | 702,970 | 20,498 | 22.8 K to 20.5 K (-10.07 %) |
| May 19 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 3,500 | 30,333 | 22,793 | 19.3 K to 22.8 K (+18.14 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 2,131 | 18,469 | 33,294 | |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 203 | 2,111 | 0 | |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 0.00 | 1,622 | 0 | 4,868 | |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 277.70 | 843 | 234,102 | 19,293 | 20.1 K to 19.3 K (-4.19 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 281.15 | 1,000 | 281,150 | 20,136 | 21.1 K to 20.1 K (-4.73 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 272.69 | 282 | 76,897 | 21,136 | 21.4 K to 21.1 K (-1.32 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 269.83 | 1,334 | 359,953 | 21,418 | 22.8 K to 21.4 K (-5.86 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 8.67 | 2,131 | 18,469 | 22,752 | 20.6 K to 22.8 K (+10.33 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 203 | 2,111 | 20,621 | 20.4 K to 20.6 K (+0.99 %) |
| Apr 03 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 0.00 | 1,622 | 0 | 20,418 | 18.8 K to 20.4 K (+8.63 %) |
| Mar 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 3,500 | 36,400 | 203 | |
| Mar 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 288.26 | 2,500 | 720,640 | 18,796 | 21.3 K to 18.8 K (-11.74 %) |
| Mar 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 283.50 | 1,000 | 283,500 | 21,296 | 22.3 K to 21.3 K (-4.49 %) |
| Mar 18 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 3,500 | 36,400 | 22,296 | 18.8 K to 22.3 K (+18.62 %) |
| Mar 16 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 8.67 | 5,000 | 43,334 | 5,971 | |
| Mar 16 2015 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 285.99 | 5,000 | 1,429,938 | 18,796 | 23.8 K to 18.8 K (-21.01 %) |